Jérôme Fayette

发表论文 384 篇 · 总被引 26653 次 · h-index 50

代表论文

Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck (2025 · JAMA · 被引 54)
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2025 · Clinical Cancer Research · 被引 27)
Survival Without Quality of Life Deterioration in the GORTEC 2014-04 “OMET” Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR (2024 · International Journal of Radiation Oncology*Biology*Physics · 被引 24)
Abstract CT009: IMvoke010: A phase III, double-blind randomized trial of atezolizumab (atezo) after definitive local therapy vs placebo in patients (pts) with high-risk locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) (2024 · Cancer Research · 被引 22)
Petosemtamab (MCLA-158) with pembrolizumab as first-line (1L) treatment of recurrent/metastatic (r/m) head and neck squamous cell carcinoma (HNSCC): Phase 2 study. (2024 · Journal of Clinical Oncology · 被引 19)
Results of a randomized, double-blind, placebo-controlled, phase 2 study (OpcemISA) of the combination of ISA101b and cemiplimab versus cemiplimab for recurrent/metastatic (R/M) HPV16-positive oropharyngeal cancer (OPC). (2024 · Journal of Clinical Oncology · 被引 18)